Truist Financial Corp Trims Stock Holdings in Markel Group Inc. $MKL

Truist Financial Corp decreased its holdings in Markel Group Inc. (NYSE:MKL) by 10.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,319 shares of the insurance provider’s stock after selling 478 shares during the period. Truist Financial Corp’s holdings in Markel Group were worth $9,284,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of MKL. Canerector Inc. lifted its position in shares of Markel Group by 191,036.0% during the third quarter. Canerector Inc. now owns 10,703,616 shares of the insurance provider’s stock worth $20,458,463,000 after acquiring an additional 10,698,016 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Markel Group by 0.4% during the third quarter. Vanguard Group Inc. now owns 1,172,997 shares of the insurance provider’s stock worth $2,242,020,000 after acquiring an additional 5,184 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of Markel Group by 1.8% during the third quarter. Principal Financial Group Inc. now owns 547,188 shares of the insurance provider’s stock worth $1,045,947,000 after acquiring an additional 9,496 shares in the last quarter. Davis Selected Advisers lifted its position in shares of Markel Group by 11.1% during the fourth quarter. Davis Selected Advisers now owns 415,160 shares of the insurance provider’s stock worth $892,496,000 after acquiring an additional 41,632 shares in the last quarter. Finally, Select Equity Group L.P. lifted its position in shares of Markel Group by 75.9% during the second quarter. Select Equity Group L.P. now owns 336,369 shares of the insurance provider’s stock worth $671,850,000 after acquiring an additional 145,146 shares in the last quarter. Hedge funds and other institutional investors own 77.12% of the company’s stock.

Markel Group Trading Up 0.6%

Shares of MKL stock opened at $1,810.91 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.63 and a current ratio of 0.63. Markel Group Inc. has a 52-week low of $1,719.41 and a 52-week high of $2,207.59. The company has a market capitalization of $22.65 billion, a PE ratio of 13.05 and a beta of 0.67. The business’s fifty day moving average is $1,931.50 and its 200 day moving average is $2,017.25.

Markel Group (NYSE:MKL) last issued its quarterly earnings data on Tuesday, April 28th. The insurance provider reported ($18.90) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $26.38 by ($45.28). Markel Group had a return on equity of 7.90% and a net margin of 10.85%.The business had revenue of $2.82 billion during the quarter, compared to analysts’ expectations of $3.66 billion. On average, equities research analysts anticipate that Markel Group Inc. will post 113.77 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Simon Wilson sold 100 shares of the stock in a transaction on Thursday, February 26th. The stock was sold at an average price of $2,079.48, for a total value of $207,948.00. Following the sale, the chief executive officer owned 2,397 shares in the company, valued at approximately $4,984,513.56. This trade represents a 4.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Diane Leopold acquired 50 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was acquired at an average price of $1,789.19 per share, for a total transaction of $89,459.50. Following the transaction, the director directly owned 550 shares of the company’s stock, valued at $984,054.50. This represents a 10.00% increase in their position. The disclosure for this purchase is available in the SEC filing. Company insiders own 1.08% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on MKL shares. Brean Capital started coverage on Markel Group in a research report on Tuesday, March 24th. They set a “neutral” rating and a $2,100.00 target price on the stock. Zacks Research downgraded Markel Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, January 19th. Wall Street Zen downgraded Markel Group from a “buy” rating to a “sell” rating in a research report on Saturday, May 2nd. Truist Financial dropped their target price on Markel Group from $2,100.00 to $1,950.00 and set a “hold” rating on the stock in a research report on Thursday, April 30th. Finally, Weiss Ratings downgraded Markel Group from a “buy (b)” rating to a “hold (c+)” rating in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $2,025.00.

Markel Group Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.